Skip to main content
Top
Published in: BMC Geriatrics 1/2021

Open Access 01-12-2021 | Research

Feasibility & Efficacy of Deprescribing rounds in a Singapore rehabilitative hospital- a randomised controlled trial

Authors: Andrew Peng Yong Wong, Tan Wan Ting, Ee Jia Ming Charissa, Tan Wee Boon, Kwan Yu Heng, Low Lian Leng

Published in: BMC Geriatrics | Issue 1/2021

Login to get access

Abstract

Background

Deprescribing is effective and safe in reducing polypharmacy among the elderly. However, the impact of deprescribing rounds remain unclear in Asian settings. Hence, we conducted this study.

Methods

An open label randomised controlled trial was conducted on patients of 65 years and above, under rehabilitation or subacute care and with prespecified medications from a Singapore rehabilitation hospital. They were randomised using a computer generated sequence.
The intervention consisted of weekly multidisciplinary team-led deprescribing rounds (using five steps of deprescribing) and usual care. The control had only usual care.
The primary outcome is the percentage change in total daily dose (TDD) from baseline upon discharge, while the secondary outcomes are the total number of medicine, total daily cost and TDD up to day 28 postdischarge, overall side-effect rates, rounding time and the challenges. Efficacy outcomes were analysed using intention-to-treat while other outcomes were analysed as per protocol.

Results

260 patients were randomised and 253 were analysed after excluding dropouts (female: 57.3%; median age: 76 years). Baseline characteristics were largely similar in both groups. The intervention arm (n = 126) experienced a greater reduction of TDD on discharge [Median (IQR): − 19.62% (− 34.38, 0.00%) versus 0.00% (− 12.00, 6.82%); p < 0.001], more constipation (OR: 3.75, 95% CI:1.75–8.06, p < 0.001) and laxative re-prescriptions (OR: 2.82, 95% CI:1.30–6.12, p = 0.009) though death and hospitalisation rates were similar. The median rounding time was 7.09 min per patient and challenges include the inconvenience in assembling the multidisciplinary team.

Conclusion

Deprescribing rounds can safely reduce TDD of medicine upon discharge compared to usual care in a Singaporean rehabilitation hospital.

Trial registration

This study is first registered at Clinicaltrials.​gov (protocol number: NCT03713112) on 19/10/2018 and the protocol can be accessed on https://​www.​clinicaltrials.​gov.
Appendix
Available only for authorised users
Literature
12.
go back to reference Orr K, Hume A. An evidence-based update on vitamins. Med Health R I. 2010;93(4):122–4.PubMed Orr K, Hume A. An evidence-based update on vitamins. Med Health R I. 2010;93(4):122–4.PubMed
14.
go back to reference Mamun K, et al. Polypharmacy and inappropriate medication use in Singapore nursing homes. Ann Acad Med Singap. 2004;33:1–4. Mamun K, et al. Polypharmacy and inappropriate medication use in Singapore nursing homes. Ann Acad Med Singap. 2004;33:1–4.
17.
go back to reference Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430–4.PubMed Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430–4.PubMed
Metadata
Title
Feasibility & Efficacy of Deprescribing rounds in a Singapore rehabilitative hospital- a randomised controlled trial
Authors
Andrew Peng Yong Wong
Tan Wan Ting
Ee Jia Ming Charissa
Tan Wee Boon
Kwan Yu Heng
Low Lian Leng
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2021
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-021-02507-0

Other articles of this Issue 1/2021

BMC Geriatrics 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.